Regeneron Pharmaceuticals Inc
UnclaimedPharmaceutical Preparation ManufacturingTarrytown, NY
Founded
1988
Primary NAICS
325412
CAGE code
544P9
Federal awards
—
Overview
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals, Veterinary Use
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $2,347,045 | 2 |
| 2026 | Department of Veterans Affairs | $0 | 11 |
| 2025 | Department of Veterans Affairs | $0 | 13 |
| 2025 | Department of Health and Human Services | -$331,708,160 | 4 |
| 2024 | Department of Veterans Affairs | $0 | 15 |
| 2024 | Department of Health and Human Services | -$1,435,528 | 4 |
| 2023 | Department of Health and Human Services | $326,475,498 | 3 |
| 2023 | Department of Veterans Affairs | $0 | 12 |
| 2022 | Department of Veterans Affairs | $494,095 | 9 |
| 2022 | Department of Defense | $0 | 2 |
| 2022 | Department of Health and Human Services | $0 | 3 |